IndraLab

Statements

Cisplatin inhibits KCNH1. 2 / 2
| 2
reach
"We demonstrate that decreased expression of Eag1 correlates with favorable prognosis in patients treated with cisplatin based adjuvant chemotherapy and predicts higher cisplatin sensitivity in ovarian cancer cells."
26079730
reach
"The decreased hEag1 expression found in OC tissue of patients treated with cisplatin based adjuvant chemotherapy was correlated with a favorable prognosis and predicted higher sensitivity to cisplatin treatment."
33562306